Medical-technology company Becton Dickinson agreed to acquire Edwards Lifesciences' Critical Care product group for $4.2 billion, increasing its access to hospital customers.
Medical-technology company Becton Dickinson agreed to acquire Edwards Lifesciences’ Critical Care product group for $4.2 billion, increasing its access to hospital customers.
